Riskpilot← Back to searchSign inGet full accessSPIKKESTAD APOTEK AS
ASActiveOrg 929500709Nye Stasjonsvei 29, 3430 SpikkestadRetail sale of pharmaceutical products · NACE 4773Est. 20228 employees
Revenue 2025
NOK 20,6M
+1% vs 2024
EBITDA margin
2.5%
+4% vs 2024
Equity ratio
9.8%
Financial strength
Net profit 2025
NOK 67K
+368% vs 2024
| Revenue | NOK 20,6M | +1% |
| EBITDA | NOK 512K | +4% |
| Net profit | NOK 67K | +368% |
| Total assets | NOK 5,1M | -9% |
| Equity | NOK 502K | +16% |
| Employees | 8 | — |
Legal name
SPIKKESTAD APOTEK AS
Org number
929500709
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
16. juli 2022
Share capital
NOK 500 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Eie og drive apotek og alt hva som hermed står i forbindelse.
Address
Nye Stasjonsvei 29, 3430 Spikkestad
Phone
+4731900707
Email
spikkestad@vitusapotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 4 448 | 16 875 | 20 317 | 20 612 |
| Staff expenses | −714 | −2 390 | −2 922 | −3 256 |
| EBITDA | −80 | 511 | 491 | 512 |
| Depreciation & amort. | −65 | −307 | −366 | −366 |
| EBIT | −144 | 204 | 125 | 145 |
| Net financials | −43 | −96 | −111 | −77 |
| Profit before tax | −188 | 108 | 14 | 68 |
| Tax | −0 | −0 | −0 | 1 |
| Net profit | −188 | 108 | 14 | 67 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 7 374 | 7 049 | 5 583 | 5 096 |
| Equity | 312 | 420 | 434 | 502 |
| Long-term debt | 2 500 | 2 395 | 1 963 | 0 |
| Short-term debt | 4 562 | 4 235 | 3 187 | 3 100 |
| Total debt | 7 062 | 6 630 | 5 149 | 4 595 |
EBITDA margin
2.5%
This company
15.8%
Market median
-84% vs market
20222025
Equity ratio
9.8%
This company
38.2%
Market median
-74% vs market
20222025
Return on equity
13.4%
This company
18.4%
Market median
+27% vs market
20222025
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20222025
Asset turnover
4.04×
This company
1.12×
Market median
+261% vs market
20222025
Debt / equity
9.16×
This company
0.62×
Market median
-1377% vs market
20222025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-06-17 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SPIKKESTAD APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Frogner | Chairman | 0 companies |
| Jan Arne Frogner | Board of Directors | 0 companies |
| Kari Marie Førde | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Board of Directors | 0 companies |